Original Research
Intramammary antibiotics in dairy goats : effect of stage of lactation, parity and milk volume on withdrawal periods, and the effect of treatment on milk compositional quality
Submitted: 13 September 2007 | Published: 13 September 2007
About the author(s)
J. Karzis,E.F. Donkin,
I.M. Petzer,
Full Text:
PDF (155KB)Abstract
High yielding goats treated with Curaclox LC (Norbrook [Pharmacia AH]) had a withdrawal period of 42 h, while low yielding goats, treated with the same product, had a withdrawal period of 74 h. The recommended withdrawal period for Curaclox LC for use in cattle is 72 h. Relatively high yielding goats treated with Rilexine 200 LC (Logos Agvet [Virbac]) had a significantly shorter withdrawal period (37 h) than that recommended for use in cattle (96 h). Low yielding goats treated with Spectrazol Milking Cow (Schering-Plough Animal Health) had a significantly longer (95 h) withdrawal period than that recommended for use in cattle (60 h).
Withdrawal periods were also influenced by stage of lactation and parity. There was a moderate positive correlation between lactation number and withdrawal period, as measured by TRIS (R2 = 0.621), and a moderate negative correlation between stage of lactation and withdrawal period (R2 = -0.669). In Trials 1, 2 and 3 combined there was a moderate negative correlation between withdrawal period and volume (R2 = -0.511) and a strong positive correlation between withdrawal period and lactation number (R2 = 0.720).
The differences in percentage milk fat, protein and lactose before, during and after treatment were not statistically significant except in Trial 3 (Curaclox LC and Rilexine 200 LC) where protein and lactose differed significantly. In Trial 2 (Spectrazol Milking Cow) milk fat percentages differed significantly between treatment and control groups as did protein percentages in Trial 3. These differences are however, not biologically meaningful.
Keywords
Metrics
Total abstract views: 5265Total article views: 4666
Crossref Citations
1. Patient variation in veterinary medicine: part I. Influence of altered physiological states
M. MARTINEZ, S. MODRIC
Journal of Veterinary Pharmacology and Therapeutics vol: 33 issue: 3 first page: 213 year: 2010
doi: 10.1111/j.1365-2885.2009.01139.x
2. Milk and serum concentration of ceftiofur following intramammary infusion in goats
E. F. Garrett, L. Dirikolu, G. S. Grover
Journal of Veterinary Pharmacology and Therapeutics vol: 38 issue: 6 first page: 569 year: 2015
doi: 10.1111/jvp.12217
3. Challenges associated with the demonstration of bioequivalence of intramammary products in ruminants
C. LAINESSE, R. GEHRING, K. PASLOSKE, G. SMITH, S. SOBACK, S. WAGNER, T. WHITTEM
Journal of Veterinary Pharmacology and Therapeutics vol: 35 issue: s1 first page: 65 year: 2012
doi: 10.1111/j.1365-2885.2012.01375.x
4. COMPOSIÇÃO DO LEITE DE CABRAS SAANEN INFECTADAS EXPERIMENTALMENTE COM Staphylococcus aureus E SUBMETIDAS A DOIS PROTOCOLOS DE TRATAMENTO
Rodolfo de Moraes Peixoto, Renata de Moraes Peixoto Araújo, Luciana Jatobá e Silva Peixoto, Werônica Souza Rocha, Maria da Conceição Aquino de Sá, Mateus Matiuzzi da Costa
Ciência Animal Brasileira vol: 17 issue: 3 first page: 449 year: 2016
doi: 10.1590/1089-6891v17i334876
5. Elimination kinetics of cephapirin sodium in milk after an 8-day extended therapy program of daily intramammary infusion in healthy lactating Holstein-Friesian cows
P.J. Gorden, M. van der List, F.D. Lehman, R.K. Lantz, P.D. Constable
Journal of Dairy Science vol: 96 issue: 7 first page: 4455 year: 2013
doi: 10.3168/jds.2012-6487
